Aerosure Evidence Base
As a class l medical device Actegy had to demonstrate that claims made in relation to the device’s safety and performance – under its normal conditions of use – are achieved.
Aerosure medic was developed in conjunction with London South Bank University, Human Performance Centre.
Completed studies with Aerosure
|London South Bank University – Dr Paul Sumners.
King’s College London – Dr David A Green, Ms T Morris
|The London South Bank Physiologists and collaborators have shown HFAO can increase acute respiratory neural drive1 and increase peak inspiratory flow 2. Also after 5 weeks of its use in respiratory training can reduce breathlessness when breathing is challenged3.
These trials were conducted in healthy individuals to support the efficacy and safety of aerosure medic
We are now working with Kings College Hospital London and other respiratory healthcare professionals to expand aerosure medic trials in specific patient populations i.e. COPD, CF and bronchiectasis.
- Sumners D P et al. Increases in inspiratory neural drive in response to rapid oscillating airflow braking forces (vibration). Resp Physiol & Neurobiol 2008; 160: 350-352
- Sumners D P et al. Respiratory modulation in response to high-frequency airway occlusion delivered during inspiration or expiration. Eur J Appl Physiol 2009. DOI 10.1007/s00421-009-1060-3
- Morris T, Sumners D P, Green D A. Inspiratory high frequency airway oscillation attenuates resistive loaded dyspnea and modulates respiratory function in young healthy individuals. PLOS ONE 2014. Vol 9, Issue 3 e91291